β-sitosterol reduces anxiety and synergizes with established anxiolytic drugs in mice
Open Access
- 1 May 2021
- journal article
- research article
- Published by Elsevier in Cell Reports Medicine
- Vol. 2 (5) , 100281
Abstract
No abstract availableKeywords
Funding Information
- European Research Council
- European Research Council
- Weizmann Institute of Science
- Weizmann Institute of Science Feinberg Graduate School
- Ministry of Aliyah and Integration
- Weizmann Institute of Science Nella and Leon Benoziyo Center for Neurological Diseases
- Carolito Stiftung (PCT/IL2018/050495, WO/2018/207178)
This publication has 60 references indexed in Scilit:
- 50 years of hurdles and hope in anxiolytic drug discoveryNature Reviews Drug Discovery, 2013
- TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusionsGenome Biology, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Convergent functional genomics of anxiety disorders: translational identification of genes, biomarkers, pathways and mechanismsTranslational Psychiatry, 2011
- Cerebral Accumulation of Dietary Derivable Plant Sterols does not Interfere with Memory and Anxiety Related Behavior in Abcg5−/− MicePlant Foods for Human Nutrition, 2011
- A negative regulator of MAP kinase causes depressive behaviorNature Medicine, 2010
- Neurogenesis-Dependent and -Independent Effects of Fluoxetine in an Animal Model of Anxiety/DepressionNeuron, 2009
- Bioactivity-Guided isolation of β-Sitosterol and Some Fatty Acids as Active Compounds in the Anxiolytic and Sedative Effects of Tilia americana var. mexicanaPlanta Medica, 2007
- The use of the elevated plus maze as an assay of anxiety-related behavior in rodentsNature Protocols, 2007
- Genetic Variant BDNF (Val66Met) Polymorphism Alters Anxiety-Related BehaviorScience, 2006